Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2023-09-11 00:00:00 ET · period of report 2023-09-08 · accession 0001822629-23-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-11 | 2023-09-08 | ANIP | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $61.94 | -3,646 | 349.7K | -1% | -$225.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-08 | F | D | 3,646 | $61.94 | 349,744 | D | — | — |